<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04884581</url>
  </required_header>
  <id_info>
    <org_study_id>CHANGE Study</org_study_id>
    <nct_id>NCT04884581</nct_id>
  </id_info>
  <brief_title>Characterization of Colorectal Neoplasia</brief_title>
  <acronym>CHANGE</acronym>
  <official_title>The CHANGE Study: Characterization Helping the Assessment of Colorectal Neoplasia in Gastrointestinal Endoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nuovo Regina Margherita Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nuovo Regina Margherita Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a post-marketing, single-arm, prospective study investigating the use of GI Genius&#xD;
      CADx device in the real-time characterization of colorectal polyps (i.e. prediction of their&#xD;
      histology during the colonoscopy). Patients enrolled will undergo a standard white-light&#xD;
      colonoscopy with the support of the latest version of the CE-marked GI Genius CADx device.&#xD;
      Colonoscopy will be performed according to the standard practice.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 12, 2021</start_date>
  <completion_date type="Actual">August 5, 2021</completion_date>
  <primary_completion_date type="Actual">July 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Negative Predictive Value (NPV)</measure>
    <time_frame>4 months</time_frame>
    <description>Negative Predictive Value (NPV) of GI Genius CADx optical diagnosis on diminutive (≤5 mm) rectosigmoid polyps</description>
  </primary_outcome>
  <other_outcome>
    <measure>Post-polypectomy surveillance interval</measure>
    <time_frame>4 months</time_frame>
    <description>Agreement in assignment of post-polypectomy surveillance intervals of the enrolled patients according to established guidelines between the combined use of GI Genius CADx as optical diagnosis for diminutive (≤5 mm) polyps and conventional histology as diagnostic tool for polyps &gt; 5 mm, and histology as diagnostic tool for all the resected polyps (regardless of size or location)</description>
  </other_outcome>
  <other_outcome>
    <measure>Performance metrics of GI Genius CADx</measure>
    <time_frame>4 months</time_frame>
    <description>Sensitivity, Specificity, Accuracy, PPV and NPV of GI Genius CADx optical diagnosis</description>
  </other_outcome>
  <other_outcome>
    <measure>Performance metrics of the endoscopist with the aid of GI Genius CADx</measure>
    <time_frame>4 months</time_frame>
    <description>Sensitivity, Specificity, Accuracy, PPV and NPV of the optical diagnosis of endoscopists assessing lesions in white-light with the help of GI Genius CADx.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">165</enrollment>
  <condition>Colonic Polyp</condition>
  <arm_group>
    <arm_group_label>GI Genius CADx device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GI Genius CADx device</intervention_name>
    <description>GI Genius System is an Intelligent Endoscopy Module designed to be an adjunct to video colonoscopy with the purpose of supporting the operating physician with artificial intelligence during colonoscopy. GI Genius CADx is the AI software that provides a histology prediction of framed polyps during real-time colonoscopy, with each polyp being classified as adenoma or non-adenoma.</description>
    <arm_group_label>GI Genius CADx device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 40 years or older undergoing screening colonoscopy for CRC&#xD;
&#xD;
          -  Ability to provide written, informed consent (approved by EC) and understand the&#xD;
             responsibilities of trial participation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  subjects at high risk for colorectal cancer&#xD;
&#xD;
          -  subjects with a personal history of CRC, IBD or hereditary polyposis or non-polyposis&#xD;
             syndromes&#xD;
&#xD;
          -  patients with previous resection of the sigmoid rectum&#xD;
&#xD;
          -  patients on anticoagulant therapy, which precludes resection / removal operations due&#xD;
             to histopathological findings&#xD;
&#xD;
          -  patients who perform an emergency colonoscopy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nuovo Regina Margherita</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 7, 2021</study_first_submitted>
  <study_first_submitted_qc>May 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nuovo Regina Margherita Hospital</investigator_affiliation>
    <investigator_full_name>Cesare Hassan</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Polyps</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

